Cedars-Sinai Accelerator+ (Techstars program historical)
Current standard terms not publicly specified · US / Los Angeles · Needs confirmation
Cedars-Sinai's current venture page describes Accelerator+, a clinical-embedding program for mid-stage health companies to run live pilots and obtain provider and patient feedback. It does not verify a current Techstars cohort, universal check, fee, equity package or deadline.
Tier 3healthcorporate
Official siteOpen in the live directory
Program intake
This listing is historical and does not represent a current application cycle.
Key facts
| Terms | Current standard terms not publicly specified |
| Stage | mid-stage health technology |
| Applications | Needs confirmation |
| Location | US / Los Angeles |
| Remote friendly | No |
| Warm intro needed | No — open application |
| Sectors | health, digital-health |
| Status | closed |
Always confirm on the official page before applying — dates and terms change.
Background
Cedars-Sinai's current venture page describes Accelerator+, a clinical-embedding program for mid-stage health companies to run live pilots and obtain provider and patient feedback. It does not verify a current Techstars cohort, universal check, fee, equity package or deadline.
How the application really works
No current public Accelerator+ intake was confirmed. Use Cedars-Sinai Ventures channels and obtain program-specific pilot and IP terms.
Tips
- Read the cited current official page before applying because program dates and terms are volatile.
- State fit with the documented stage, geography, and attendance model; do not rely on an aggregator's old terms.
- Ask for the complete investment, fee, and follow-on documents when the public page does not publish them.
Watch out for
- No current universal cash, fee, equity, IP or pilot-commercialization terms are published.
- The old Cedars-Sinai Techstars label is stale. Cedars-Sinai now describes Accelerator+ for embedded pilots, but does not publish a current cohort application or standardized investment deal.
Track record
- Cedars-Sinai reports 1,100+ patents, more than $1B in technology-transfer revenue and 33% of inventions licensed or optioned; these are institution-wide, not Accelerator+ cohort outcomes.
Clinical-pilot fit is central, but no public application volume or acceptance rate is published.
Frequently asked questions
- Is this program currently accepting applications?
- No current public Accelerator+ intake was confirmed. Use Cedars-Sinai Ventures channels and obtain program-specific pilot and IP terms.
- What are the current economics?
- No current universal cash, fee, equity, IP or pilot-commercialization terms are published.
- How large and long is the program?
- Current Accelerator+ cohort size and cadence are not published. Embedded clinical pilots with provider and patient feedback for mid-stage health companies.
- Can founders participate remotely?
- Clinical embedding implies Los Angeles participation; exact attendance requirements are unpublished.
- What happens after the program?
- Pilot evidence and clinical stakeholder access; no automatic investment or procurement promise.
Related accelerators
Sources
- www.cedars-sinai.org/about/ventures.html — Official current Accelerator+ positioning and institution-wide innovation outcomes (checked 2026-08-10)